These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease. Stojsavljević S; Gomerčić Palčić M; Virović Jukić L; Smirčić Duvnjak L; Duvnjak M World J Gastroenterol; 2014 Dec; 20(48):18070-91. PubMed ID: 25561778 [TBL] [Abstract][Full Text] [Related]
5. Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease. du Plessis J; van Pelt J; Korf H; Mathieu C; van der Schueren B; Lannoo M; Oyen T; Topal B; Fetter G; Nayler S; van der Merwe T; Windmolders P; Van Gaal L; Verrijken A; Hubens G; Gericke M; Cassiman D; Francque S; Nevens F; van der Merwe S Gastroenterology; 2015 Sep; 149(3):635-48.e14. PubMed ID: 26028579 [TBL] [Abstract][Full Text] [Related]
6. Nonalcoholic fatty liver disease and metabolic syndrome in postmenopausal women. Rodrigues MH; Bruno AS; Nahas-Neto J; Santos ME; Nahas EA Gynecol Endocrinol; 2014 May; 30(5):325-9. PubMed ID: 24460502 [TBL] [Abstract][Full Text] [Related]
8. Chronic inflammation as a molecular basis of nonalcoholic steatohepatitis: role of macrophages and fibroblasts in the liver. Itoh M; Ogawa Y; Suganami T Nagoya J Med Sci; 2020 Aug; 82(3):391-397. PubMed ID: 33132423 [TBL] [Abstract][Full Text] [Related]
9. Crosstalk Between Liver Macrophages and Surrounding Cells in Nonalcoholic Steatohepatitis. Li H; Zhou Y; Wang H; Zhang M; Qiu P; Zhang M; Zhang R; Zhao Q; Liu J Front Immunol; 2020; 11():1169. PubMed ID: 32670278 [TBL] [Abstract][Full Text] [Related]
10. Th17 involvement in nonalcoholic fatty liver disease progression to non-alcoholic steatohepatitis. Chackelevicius CM; Gambaro SE; Tiribelli C; Rosso N World J Gastroenterol; 2016 Nov; 22(41):9096-9103. PubMed ID: 27895397 [TBL] [Abstract][Full Text] [Related]
11. The Role of Tissue Macrophage-Mediated Inflammation on NAFLD Pathogenesis and Its Clinical Implications. Alisi A; Carpino G; Oliveira FL; Panera N; Nobili V; Gaudio E Mediators Inflamm; 2017; 2017():8162421. PubMed ID: 28115795 [TBL] [Abstract][Full Text] [Related]
13. The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Kazankov K; Jørgensen SMD; Thomsen KL; Møller HJ; Vilstrup H; George J; Schuppan D; Grønbæk H Nat Rev Gastroenterol Hepatol; 2019 Mar; 16(3):145-159. PubMed ID: 30482910 [TBL] [Abstract][Full Text] [Related]
14. Current and Potential Therapies Targeting Inflammation in NASH. Albhaisi S; Noureddin M Front Endocrinol (Lausanne); 2021; 12():767314. PubMed ID: 34925237 [TBL] [Abstract][Full Text] [Related]
15. Non-alcoholic fatty liver disease, obesity and the metabolic syndrome. Dietrich P; Hellerbrand C Best Pract Res Clin Gastroenterol; 2014 Aug; 28(4):637-53. PubMed ID: 25194181 [TBL] [Abstract][Full Text] [Related]
16. Triggering and resolution of inflammation in NASH. Schuster S; Cabrera D; Arrese M; Feldstein AE Nat Rev Gastroenterol Hepatol; 2018 Jun; 15(6):349-364. PubMed ID: 29740166 [TBL] [Abstract][Full Text] [Related]
17. The Multifaceted Roles of Macrophages in NAFLD Pathogenesis. Vonderlin J; Chavakis T; Sieweke M; Tacke F Cell Mol Gastroenterol Hepatol; 2023; 15(6):1311-1324. PubMed ID: 36907380 [TBL] [Abstract][Full Text] [Related]